IRAY TECHNOLOGY(SH:688301) Xin Lang Cai Jing·2025-09-15 02:09Company Overview - Yirui Technology, established on March 7, 2011, and listed on September 18, 2020, is located in Shanghai and specializes in the research, production, sales, and service of digital X-ray detectors [1] - The company's main revenue sources include detector sales (81.21%), core component sales (7.66%), solution/technical service revenue (5.89%), accessory sales (4.57%), and rental income (0.66%) [1] Financial Performance - As of June 30, 2025, Yirui Technology reported a revenue of 1.067 billion yuan, representing a year-on-year growth of 3.94%, and a net profit attributable to shareholders of 335 million yuan, with an increase of 8.82% year-on-year [2] - The company has distributed a total of 789 million yuan in dividends since its A-share listing, with 557 million yuan distributed over the past three years [3] Stock Performance - On September 15, Yirui Technology's stock price decreased by 2.05%, trading at 109.20 yuan per share, with a market capitalization of 21.864 billion yuan [1] - The stock has seen a year-to-date increase of 61.60%, a decline of 7.84% over the last five trading days, a slight increase of 1.10% over the last 20 days, and a rise of 24.67% over the last 60 days [1] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 21.67% to 6,990, with an average of 28,643 circulating shares per person, up by 15.02% [2] - Among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF is a new entrant holding 3.926 million shares, while Jingshun Changcheng New Energy Industry Stock A has exited the list [3] Market Position - Yirui Technology operates within the pharmaceutical and biological industry, specifically in the medical device sector, and is associated with concepts such as oral healthcare, specialized and innovative enterprises, mid-cap stocks, margin financing, and share buybacks [1]